Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (18 ops.)
Latest filing published 07 Oct 2026 for 4D Molecular Therapeutics, Inc., €668k. Read the official filing
Filing timeline
BuySaleDavid Kirn
Insider track record
Disclosed buys
0
Disclosed sells
18
Signal history
David Kirn: trading record in brief
David Kirn discloses dealings in 4D Molecular Therapeutics, Inc. to SEC (Form 4). The record holds 22 filings, for trades running from 15 December 2022 to 5 October 2026.
The open-market record consists of 18 sales worth €7.4M, with no purchase. The totals exclude 1 filing filed without an amount. Besides market trades, the filings include 3 option exercises. Since January 2026: no purchases and 12 sales on the market.
Most recently, on 7 October 2026, the filings show an open-market sale worth €668k in 4D Molecular Therapeutics, Inc. Typically, a trade is published a median of 2 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to David Kirn
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations22 total
58,061 shares@ US$12.9215Common StockSEC:0001193125-26-417068:0
272 shares@ US$13.6104Common StockSEC:0001193125-26-417068:1
58,333 shares@ US$13.9030.098% mcap9.7% of flowCommon StockSEC:0001193125-26-393243:0
50,000 shares@ US$4.140.025% mcap2.5% of flowCommon StockSEC:0001193125-26-361096:0
43,149 shares@ US$15.35660.080% mcap7.9% of flowCommon StockSEC:0001193125-26-361096:1
25,927 shares@ US$16.41730.051% mcap5.1% of flowCommon StockSEC:0001193125-26-361096:2
26,842 shares@ US$10.23010.033% mcap3.3% of flowCommon StockSEC:0001193125-26-335115:0
12,415 shares@ US$10.04610.015% mcap1.5% of flowCommon StockSEC:0001193125-26-333014:0
42,608 shares@ US$12.86560.067% mcap6.6% of flowCommon StockSEC:0001834021-26-000004:0
442 shares@ US$12.83550.0007% mcap0.1% of flowCommon StockSEC:0001834021-26-000004:2
15,283 shares@ US$12.01070.022% mcap2.2% of flowCommon StockSEC:0001834021-26-000004:1
114,746 sharesCommon StockSEC:0001834021-26-000002:0
1,922 shares@ US$10.01970.2% of flowCommon StockSEC:0001193125-26-253740:0
11,653 shares@ US$14.422.1% of flowCommon StockSEC:0000950170-24-083303:0
12,930 shares@ US$14.422.4% of flowCommon StockSEC:0000950170-24-077944:0
92,001 shares@ US$27.128232.0% of flowCommon StockSEC:0000950170-24-014091:0
5,696 shares@ US$18.40791.3% of flowCommon StockSEC:0000950170-24-007477:0
28,632 shares@ US$17.26856.2% of flowCommon StockSEC:0000950170-24-002945:0
600,000 shares0Common StockSEC:0001140361-23-023022:0
17,090 shares@ US$20.93144.6% of flowCommon StockSEC:0001567619-23-003706:0
10,899 shares@ US$20.03372.8% of flowCommon StockSEC:0001567619-23-001163:0
31,433 shares@ US$23.56029.6% of flowCommon StockSEC:0001567619-22-021815:0
22 of 22 declarations
